Salivary HOTAIR and PVT1 as novel biomarkers for early pancreatic cancer

Oncotarget

Volumn 7, Issue 18, 2016, Pages 25408-25419

  Xie, Zijun ^a   Chen, Xiaoliang ^a   Li, Jianzhong ^a   Guo, Yunwei ^a   Li, Haijiao ^a   Pan, Xuemei ^a   Jiang, Jie ^a   Liu, Huiling ^a   Wu, Bin ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Biomarker; Diagnosis; HOTAIR; Pancreatic cancer; PVT1

Indexed keywords

CA 19-9 ANTIGEN; H19; HOX TRANSCRIPT ANTISENSE INTERGENIC RNA; HOXA DISTAL TRANSCRIPT ANTISENSE RNA; LONG UNTRANSLATED RNA; METASTASIS ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1; PLASMACYTOMA VARIANT TRANSLOCATION 1; UNCLASSIFIED DRUG; LONG NON-CODING RNA HOTAIRM1, HUMAN; MICRORNA; PVT1 LONG-NON-CODING RNA, HUMAN; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; COLON CANCER; CONTROLLED STUDY; ESOPHAGUS CANCER; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LIVER CANCER; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PANCREAS RESECTION; PANCREAS TUMOR; POLYMERASE CHAIN REACTION; PROSTATE CANCER; RECEIVER OPERATING CHARACTERISTIC; SALIVA LEVEL; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; UPREGULATION; UTERINE CERVIX CANCER; CARCINOMA; CHEMISTRY; EARLY CANCER DIAGNOSIS; METABOLISM; MIDDLE AGED; PROCEDURES; SALIVA; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CARCINOMA; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PANCREATIC NEOPLASMS; RNA, LONG NONCODING; SALIVA; SENSITIVITY AND SPECIFICITY; UP-REGULATION; YOUNG ADULT;

EID: 84967316568     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.8323     Document Type: Article

References (23)

1. Sharma C, Eltawil KM, Renfrew PD, Walsh MJ, Molinari M. Advances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990-2010. World J Gastroenterol. 2011; 17:867-897.
2. Poruk KE, Firpo MA, Adler DG, Mulvihill SJ. Screening for pancreatic cancer: Why, how, and who? Ann Surg. 2013; 257:17-26.
3. Wu E, Zhou S, Bhat K, Ma Q. CA 19-9 and pancreatic cancer. Clin Adv Hematol Oncol. 2013; 11:53-55.
4. Ballehaninna UK, Chamberlain RS. The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal. J Gastrointest Oncol. 2012; 3:105-119.
5. Ma C, Nong K, Zhu H, Wang W, Huang X, Yuan Z, Ai K. H19 promotes pancreatic cancer metastasis by derepressing let-7's suppression on its target HMGA2-mediated EMT. Tumour Biol. 2014; 35:9163-9169.
6. Kim K, Jutooru I, Chadalapaka G, Johnson G, Frank J, Burghardt R, Kim S, Safe S. HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene. 2013; 32:1616-1625.
7. Li Z, Zhao X, Zhou Y, Liu Y, Zhou Q, Ye H, Wang Y, Zeng J, Song Y, Gao W, Zheng S, Zhuang B, Chen H, et al. The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer. J Transl Med. 2015; 13:84.
8. Jiao F, Hu H, Yuan C, Wang L, Jiang W, Jin Z, Guo Z, Wang L. Elevated expression level of long noncoding RNA MALAT-1 facilitates cell growth, migration and invasion in pancreatic cancer. Oncol Rep. 2014; 32:2485-2492.
9. You L, Chang D, Du HZ, Zhao YP. Genome-wide screen identifies PVT1 as a regulator of Gemcitabine sensitivity in human pancreatic cancer cells. Biochem Biophys Res Commun. 2011; 407:1-6.
10. Wang Y, Li Z, Zheng S, Zhou Y, Zhao L, Ye H, Zhao X, Gao W, Fu Z, Zhou Q, Liu Y, Chen R. Expression profile of long non-coding RNAs in pancreatic cancer and their clinical significance as biomarkers. Oncotarget. 2015; 6:35684-35698 doi: 10.18632/oncotarget.5533..
11. Lee YH, Wong DT. Saliva: An emerging biofluid for early detection of diseases. Am J Dent. 2009; 22:241-248.
12. Zhang Y, Sun J, Lin CC, Abemayor E, Wang MB, Wong DT. The emerging landscape of salivary diagnostics. Oral Health Dent Manag. 2014; 13:200-210.
13. Xie ZJ, Chen G, Zhang XC, Li DF, Huang J, Li ZJ. Saliva supernatant miR-21: A novel potential biomarker for esophageal cancer detection. Asian Pac J Cancer Prev. 2012; 13:6145-6149.
14. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015; 65:87-108.
15. De La Cruz MS, Young AP, Ruffin MT. Diagnosis and management of pancreatic cancer. Am Fam Physician. 2014; 89:626-632.
16. Tong YS, Wang XW, Zhou XL, Liu ZH, Yang TX, Shi WH, Xie HW, Lv J, Wu QQ, Cao XF. Identification of the long non-coding RNA POU3F3 in plasma as a novel biomarker for diagnosis of esophageal squamous cell carcinoma. Mol Cancer. 2015; 14:3.
17. Kladi-Skandali A, Michaelidou K, Scorilas A, Mavridis K. Long noncoding RNAs in digestive system malignancies: A novel class of cancer biomarkers and therapeutic targets? Gastroenterol Res Pract. 2015; 2015:319861.
18. Gao K, Zhou H, Zhang L, Lee JW, Zhou Q, Hu S, Wolinsky LE, Farrell J, Eibl G, Wong DT. Systemic disease-induced salivary biomarker profiles in mouse models of melanoma and non-small cell lung cancer. PLoS One. 2009; 4:e5875.
19. Zhang L, Farrell JJ, Zhou H, Elashoff D, Akin D, Park NH, Chia D, Wong DT. Salivary transcriptomic biomarkers for detection of resectable pancreatic cancer. Gastroenterology. 2010; 138:949-957.
20. Xie Z, Chen G, Zhang X, Li D, Huang J, Yang C, Zhang P, Qin Y, Duan Y, Gong B, Li Z. Salivary microRNAs as promising biomarkers for detection of esophageal cancer. PLoS One. 2013; 8:e57502.
21. Xie Z, Yin X, Gong B, Nie W, Wu B, Zhang X, Huang J, Zhang P, Zhou Z, Li Z. Salivary microRNAs show potential as a noninvasive biomarker for detecting resectable pancreatic cancer. Cancer Prev Res (Phila). 2015; 8:165-173.
22. Margaret AT, Joseph H, Martha BP, Pablo AJ, John PH, Aaron RS, Stephen B, Srinadh K, Sarah PT, Edgar BJ, Albert K, Robert SW, Boris K, et al. National Comprehensive Cancer Network: Practice Guidelines in Oncology v.2.2010. Fort Washington, PA: National Comprehensive Cancer Network. 2011.
23. Edge S, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual (7th ed). New York, NY:Springer. 2010.